#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Autoimmune hepatitis Neuropathic arthropathy Cardiac sarcoidosis Cutaneous calcification Synovitis Hodgkin's disease recurrent Synovial sarcoma recurrent Oropharyngeal cancer recurrent Activated PI3 kinase delta syndrome Alpha-1 antitrypsin deficiency Gaucher's disease type III Brain stem glioma Nasopharyngeal cancer Lymphoma Medulloblastoma More trials…

    Learn about Rare Diseases

    Ornithine transcarbamoylase deficiency – Life with Disease Von Willebrand’s disease – Basic Information Haemophilia A with anti factor VIII – Treatment Hereditary optic atrophy – Treatment Alternating hemiplegia of childhood – Life with Disease Brain stem glioma – Trials in Disease Sarcoma Prolymphocytic leukaemia – Life with Disease Behcet’s syndrome – Diagnostics Glycogen storage disease type II – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Pseudoephedrine Hydrochloride TAGRAXOFUSP SILYMARIN TAZAROTENE Mps-214 Dorzolamide Hydrochloride Livmoniplimab Esmolol Hydrochloride Milrinone Salmeterol Xinafoate Clindamycin Phosphate 99MTC-EUK-(SO3)CY5-MAS3 Purified Egg Phospholipids GXV813 12 Grass Pollen Mixture Paroxetine Hydrochloride Ep0042 Etoricoxib Poltreg-T1D Fluvastatin More therapies…

    Learn about Your Condition

    Retinoblastoma Immune-mediated renal disorder Periarthritis Hodgkin's disease refractory Ependymoma Vaginal infection Hyperinsulinism Hidradenitis Irritable bowel syndrome Intracranial aneurysm Medulloblastoma Peritoneal neoplasm Hypomagnesaemia Peritoneal abscess Hypervolaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Digestive System Diseases

  • Study of ly4395089 and mirikizumab in adults with moderately to severely active Crohn’s disease

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Colitis
    • Colitis ulcerative
    • Crohn’s disease
    Investigated Drugs:
    • Mirikizumab
    Belgium Germany Hungary Italy Poland
  • Study of mirikizumab versus azathioprine in newly diagnosed moderate-to-severe Crohn’s disease patients

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Mirikizumab
    • Azathioprine
    Germany
  • Efficacy of sufentanil versus fentanyl for postoperative pain in patients undergoing urgent laparoscopic cholecystectomy

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Fentanyl
    • Sufentanil
    Spain
  • Celecoxib versus placebo for pain and quality of life in adult patients with chronic pancreatitis

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Pancreatitis chronic
    Investigated Drugs:
    • Pantoprazole Sodium Sesquihydrate
    • Celecoxib
    Denmark
  • Pembrolizumab for Patients with Localised dMMR Colon Cancer: Neoadjuvant and Organ-Sparing Treatment Study

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Colon cancer
    Investigated Drugs:
    • Pembrolizumab
    Denmark
  • A study to evaluate the effectiveness of ispaghula husk in patients with low anterior resection syndrome after rectal cancer surgery

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Low anterior resection syndrome
    Investigated Drugs:
    • ISPAGHULA HUSK
    Norway
Previous Page
1 … 46 47 48 49 50 … 93
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.


European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!